NanoViricides, Inc. (NASDAQ:NNVC)

PRESS RELEASE

published on 07/14/2025 at 12:30, 8 months 5 days ago

Adaptive Clinical Protocol Design for Phase II MPox Clade I Treatment with a Novel Broad-Spectrum Drug NV-387 is Almost Complete, Reports NanoViricides
NanoViricides, Inc. announces design completion of adaptive clinical trial protocol for MPox Virus treatment. Trial to evaluate dosing regimen, safety, and effectiveness in 80 patients

NV-387 Clinical Trial NanoViricides Inc. Antiviral Mpox Virus
BRIEF

published on 07/01/2025 at 12:35, 8 months 18 days ago

NanoViricides fait passer le NV-387 en phase II pour le traitement MPox

NV-387 Essai De Phase II Médicaments Antiviraux Traitement MPox Réserve Stratégique
BRIEF

published on 07/01/2025 at 12:35, 8 months 18 days ago

NanoViricides Advances NV-387 to Phase II for MPox Treatment

NV-387 Antiviral Drugs Phase II Trial MPOX Treatment Strategic Stockpile
PRESS RELEASE

published on 07/01/2025 at 12:30, 8 months 18 days ago

There is a Strong Business Case for Phase II Clinical Program for Treatment of MPox Infection Using NV-387, an Industry-Leading Broad-Spectrum Antiviral Drug Candidate
NanoViricides, Inc. announces advancing lead candidate NV-387 into Phase II clinical development for MPox. Protocol development and site addition underway in the DRC. Focus on antiviral drug against MPox/Smallpox

NV-387 NanoViricides Inc. Antiviral Drug Mpox Phase II
BRIEF

published on 06/18/2025 at 12:35, 9 months 1 day ago

NanoViricides Presents NV-387 as Leading Antiviral Defense

Pandemic Preparedness NV-387 Antiviral COVID Variants Bird Flu Threat Broad-spectrum Efficacy
BRIEF

published on 06/18/2025 at 12:35, 9 months 1 day ago

NanoViricides présente le NV-387 comme un antiviral de premier plan

Antiviral NV-387 Variantes De La COVID Menace De Grippe Aviaire Efficacité À Large Spectre Préparation Aux Pandémies
PRESS RELEASE

published on 06/18/2025 at 12:30, 9 months 1 day ago

With Rising Variants of COVID and Bird Flu, the Single Broad-Spectrum Antiviral NV-387 Would be the Best Partner for Preparedness, Says NanoViricides' Dr. Diwan
NanoViricides, Inc. announces the effectiveness of broad-spectrum antiviral drug NV-387 against COVID variants and Bird Flu, positioning it well for pandemic preparedness

NanoViricides NV-387 Antiviral Drug Bird Flu COVID Variants
BRIEF

published on 06/04/2025 at 13:00, 9 months 15 days ago

NanoViricides se prépare à une étude animale sur un médicament contre la rougeole

NanoViricides NV-387 Épidémie De Rougeole Déclin Des Vaccins Étude Antivirale
BRIEF

published on 06/04/2025 at 13:00, 9 months 15 days ago

NanoViricides Prepares for Measles Drug Animal Study

NanoViricides NV-387 Measles Outbreak Vaccine Decline Antiviral Study
PRESS RELEASE

published on 06/04/2025 at 12:55, 9 months 15 days ago

NanoViricides Measles Drug Development Animal Study is Imminent
NanoViricides, Inc. announces progress in developing a Measles drug, NV-387, a broad-spectrum antiviral with potential to combat Measles outbreaks and vaccine failures

NV-387 NanoViricides Inc. Antiviral Clinical Stage Measles Drug

Published on 03/20/2026 at 03:10, 5 hours 44 minutes ago

Future Fuels Announces Filing of Amended and Restated Life Offering Document
Published on 03/20/2026 at 00:20, 8 hours 34 minutes ago

Prospect Ridge To Host Investor Webinar With Presentation And Audience Q&A
Published on 03/20/2026 at 00:20, 8 hours 34 minutes ago

Reeflex Solutions Inc. Announces Revocation of Management Cease Trade Order
Published on 03/19/2026 at 21:16, 11 hours 38 minutes ago

Unusual Machines, Inc. Announces Proposed Public Offering
Published on 03/19/2026 at 14:20, 18 hours 34 minutes ago

CBMJ CEO Rips Legacy Liberal Media Over Iran Coverage on The Schaftlein Report

View all ACCESSWIRE

Published on 03/20/2026 at 08:30, 23 minutes ago

freenet confirms preliminary results for the 2025 financial year, proposed dividend per share of EUR 2.07 and guidance for the 2026 financial year
Published on 03/20/2026 at 08:30, 24 minutes ago

À Londres, l’Office National du Tourisme de Thaïlande dévoile sa campagne « Healing Journey Thailand »
Published on 03/20/2026 at 08:30, 24 minutes ago

Energiekontor AG: Further financial close achieved for Bützfleth wind project
Published on 03/20/2026 at 08:00, 54 minutes ago

Transaction in Own Shares
Published on 03/20/2026 at 08:00, 54 minutes ago

Cairn Homes Plc: Result of Secondary Placing

View all EQS

Published on 03/19/2026 at 18:00, 14 hours 54 minutes ago

Filing of the 2025 Universal Registration Document
Published on 03/19/2026 at 18:00, 14 hours 54 minutes ago

Mise à disposition du Document d’Enregistrement Universel 2025
Published on 03/19/2026 at 15:00, 17 hours 54 minutes ago

Statement Accor
Published on 03/19/2026 at 15:00, 17 hours 54 minutes ago

Communication Accor
Published on 03/19/2026 at 08:45, 1 day ago

Deezer et Sonos renouvellent et étendent leur partenariat stratégique

View all LES ECHOS COMFI WIRE

News